Location: San Diego, CA
CIK: 0001232621 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $584M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ODONATE THERAPEUTICS INC | 14,075,269 | $366M | 62.7% | $25.08 | — | COM | 676079106 |
| HRTX | HERON THERAPEUTICS INC | 5,514,096 | $102M | 17.5% | $14.10 | +30.5% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 4,938,893 | $43.46M | 7.4% | $15.94 | — | COM | 503459604 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,965,485 | $34.55M | 5.9% | $16.31 | -23.9% | COM | 77313F106 |
| — | AVROBIO INC | 829,121 | $11.71M | 2.0% | $14.12 | — | COM | 05455M100 |
| — | CELGENE CORP | 111,844 | $11.11M | 1.9% | $94.34 | — | COM | 151020104 |
| PBYI | PUMA BIOTECHNOLOGY INC | 349,400 | $3.761M | 0.6% | $30.17 | -64.2% | COM | 74587V107 |
| — | NUCANA PLC | 500,000 | $3.62M | 0.6% | $7.24 | — | SPONSORED ADR | 67022C106 |
| — | G1 THERAPEUTICS INC | 150,000 | $3.417M | 0.6% | $30.66 | — | COM | 3621LQ109 |
| PRTA | PROTHENA CORP PLC | 423,823 | $3.323M | 0.6% | $11.57 | -23.2% | SHS | G72800108 |
| — | IVERIC BIO INC | 600,000 | $672K | 0.1% | $1.30 | — | COM | 46583P102 |
| — | CELLECTAR BIOSCIENCES INC | 235,701 | $471K | 0.1% | $2.18 | — | COM PAR | 15117F500 |